The effects of zinc and manganese on the reductive dissolution of hematite by the dissimilatory metal-reducing bacterium (DMRB) Shewanella putrefaciens CN32 were studied in batch culture. Experiments were conducted with hematite (2.0 g L Ϫ1 ) in 10 mM PIPES (pH 6.8), and H 2 as the electron donor under nongrowth conditions (10 8 cell mL Ϫ1 ), spiked with zinc (0.02-0.23 mM) or manganese (0.02-1.8 mM) and incubated for 5 days. Zinc inhibition was calculated based on the 5-day extent of hematite bioreduction in the absence and presence of zinc. Zinc inhibition of hematite bioreduction increased with anthraquinone-2,6-disulfonate (AQDS), a soluble electron shuttling agent, and ferrozine, a strong Fe(II) complexant. Both amendments would otherwise stimulate hematite bioreduction. These amendments did not significantly increase zinc sorption, but may have increased zinc toxicity by some unknown mechanism. At equal total Me(II) concentrations, zinc inhibited hematite reduction more than manganese and caused greater cell death. At equal sorbed Me(II) concentrations, manganese inhibited hematite reduction more than zinc and caused greater cell death. Results support the interpretation that Me(II) toxicity was more important than Me(II) sorption/surface blockage in inhibiting hematite reduction.
INTRODUCTION T
HE DISSIMILATORY REDUCTION of Fe(III) has been recognized as a viable option for the in situ bioremediation of contaminated sediments and aquifers (Lovley et al., 1996; Fredrickson et al., 1998; Urrutia et al., 1998 Urrutia et al., , 1999 . The abundance of ferric-containing minerals found within most sediments can greatly influence the fate and transport of organic and inorganic contaminants. While microbial iron reduction may be a feasible option for these remediation efforts, little is known about bioreduction processes in the presence of heavy metal cocontaminants. Previous studies have shown that the rate or extent of microbial Fe(III) reduction is influenced by the presence of heavy metals such as Cu(II) (Markwiese and Colberg, 2000) , Ni(II) Parmar et al., 2001) , Co(III) , and Zn(II) (Cooper et al., 2000; Stone et al., 2006) , primarily due to heavy metal toxicity/lethality to dissimilatory metalreducing bacteria (DMRB). Metal-microbe interactions are well documented (Baath, 1989; Kushner, 1993; Gadd, 1996; Warren and Haack, 2001) , and may exert a significant influence on the effectiveness of bioremediation at contaminated sites.
We recently reported on zinc inhibition of aerobic growth, nitrate bioreduction, ferric citrate bioreduction, and hematite bioreduction with Shewanella putrefaciens CN32 (Stone et al., 2006) . S. putrefaciens is a Gram-negative facultative anaerobe capable of reducing crystalline and soluble iron oxides (Cooper et al., 2000; Royer et al., 2002a Royer et al., , 2002b , nitrate, and a variety of toxic metals and radionuclides such as Cr(VI) (Fendorf et al., 2000; Wielinga et al., 2001) , U(VI) (Brooks et al., 2003) , and Tc(VII) (Liu et al., 2002a; Wildung et al., 2000) . Our experiments revealed that soluble electron acceptors were more sensitive to the presence of zinc than solid-phase hematite, and that low concentrations of zinc stimulated only solid-phase hematite bioreduction. We speculated that the formation of zinctolerant biofilms on hematite surfaces was a possible mechanism for the differences observed (Costerton et al., 1995; Teitzel and Parsek, 2003; Stone et al., 2006) .
The enhancement of hematite bioreduction by two soluble amendments, anthraquinone-2-6-disulfonate (AQDS), and ferrozine, was reported by Royer et al. (2002b) . AQDS can serve as an alternative soluble electron acceptor and shuttle electrons between DMRB and solid-phase ferric oxides (Lovley et al., 1996; Fredrickson et al., 1998; Zachara et al., 1998; Hacherl et al., 2001) . Ferrozine can complex Fe(II) (Stookey, 1970) , thus decreasing Fe(II) sorption onto oxide or cell surfaces and limiting the occurrence of Fe(II)-promoted "surface passivation" (Royer et al., 2002a) . The role of AQDS as an electron shuttling quinone has been well documented Zachara et al., 1998; Kieft et al., 1999) ; however, its function and effectiveness in the presence of divalent metals other than biogenic Fe(II) is relatively unknown. Fredrickson et al. (2001) reported that AQDS did not enhance the bioreduction of Ni(II)-or Co(III)-substituted goethite by S. putrefaciens CN32. This lack of enhancement, compared to increased bioreduction in the absence of metals, was attributed to sorbed Ni(II) or Co(II/III) that occupied goethite surface sites and thus slowed reoxidation of reduced AQDS (AH 2 DS) by goethite. Divalent metals could inhibit the bioreduction of solidphase metal oxides by at least two possible mechanisms. Me(II) toxicity leading to cell death could decrease metal oxide bioreduction. Me(II) sorption blocking bioreducible metal oxide surface sites could also decrease metal oxide bioreduction. The objectives of this study were to (1) determine the predominant mechanism of Me(II) inhibition of hematite bioreduction using zinc and manganese, and (2) determine the effectiveness of amendments known to stimulate hematite bioreduction in the presence of zinc.
EXPERIMENTAL PROTOCOLS
All experimental procedures have been previously described (Royer et al., 2002a; Stone et al., 2006) ; however, important descriptions are provided below.
Micro-organism and culture conditions
Shewanella putrefaciens CN32 was grown aerobically on tryptic soy broth without dextrose at 20°C. Cells were harvested by centrifugation (4,900 ϫ g, 10 min, 20°C) from a 16-h-old culture (late log phase). The cells were washed three times in 10 mM 1,4-piperazinediethanosulfonic acid (PIPES; pH ϭ 6.8), with the final wash deoxygenated to remove residual oxygen. Cell density was determined by absorbance at 420 nm.
Chemicals
Hematite powder was obtained from J.T. Baker (Phillipsburg, NJ) and heated to 550°C in air overnight before use to remove any residual organic carbon. AQDS (Sigma-Aldrich, St. Louis, MO) and ferrozine (J. T. Baker) were used as received, and filtered (0.2 m) stock solutions were prepared in PIPES buffer.
Hematite bioreduction
A "master reactor" approach was used to ensure consistent chemical and biological conditions in each series of experiments (Royer et al., 2002b; Stone et al., 2006) . A master reactor was prepared by first combining the hematite and inoculum in a 120-mL serum bottle. All solutions (except the zinc and manganese stocks) were prepared in 10 mM PIPES (pH 6.8). Before metal or amendment addition, three 10-mL aliquots were removed, which served as biotic no-amendment, no-metal controls. The amendment (final concentration of 1.46 mM ferrozine or 50 M AQDS) was then added and three 10-mL aliquots were removed which served as biotic withamendment, no-zinc controls. Zinc was incrementally added to the master reactor from an acidified, deoxy- (Stookey, 1970) . Dissolved and 0.5 H HCl extractable metal concentrations were measured from the corresponding dissolved and extractable Fe(II) filtrate samples by flame AAS after preservation with conc. HNO 3 . Solution pH of the dissolved filtrate was determined in the anaerobic chamber using a combination pH electrode. The pH of the experiments never varied outside the range of 6.6-7.0. Cell viability was measured using the Baclight bacterial viability kit (Molecular Probes, Eugene, OR). Viable cells were recognized by an apple green fluorescence indicating SYTO 9 stain absorption, while nonviable cells were recognized by red fluorescence caused by propidium iodide uptake, quenching the green SYTO 9 fluorescence (Sani et al., 2001; Hu et al., 2003; Teitzel and Parsek, 2003; Stone et al., 2006) . Viable cell counts were made at 64ϫ magnification with a Zeiss epifluorescence microscope (Zeiss, Jena, Germany). Freely dispersed cell viability was calculated based upon the average from five field counts (each field being 2.64 ϫ 10 Ϫ4 cm 2 ) for each sample (one per reactor). Cells visibly attached to hematite particles (i.e., localized biofilms) were not counted due uncertainties related to stain uptake.
Zinc and manganese partitioning
Experiments were performed to determine the partitioning of zinc and manganese to 10 8 viable cells mL Ϫ1 , 2.0 g L Ϫ1 hematite during bioreduction experimental conditions described above. Dissolved Me(II) and 0.5 N HCl extractable Me(II) concentrations were determined from incubated serum bottles. Sorbed metal concentrations were operationally defined as the difference between the 0.5 N HCl extractable and dissolved (both passing through a 0.2-m filter) metal concentrations measured after a 24-h reaction period. Incubation periods ranged from 1 to 5 days for zinc, and 5 days for manganese. For zinc experiments, variable biogenic Fe(II) concentrations ranged from 0.09-0.30 mM 0.5 N HCl extractable Fe(II). For manganese experiments, variable biogenic Fe(II) concentrations ranged from 0.10-0.20 mM 0.5 N HCl extractable Fe(II). Since our experiments contained two sorbents (hematite and cells), sorbed Me(II) concentrations were calculated as the difference between the 0.5 N HCl extractable and dissolved Me(II) concentrations and are reported as mmol of Me(II) per m 2 total sorbent surface area. Sorbent concentrations were 2.0 g L Ϫ1 hematite and 0.064 g L Ϫ1 cells, with cell mass estimated using an average cell weight of 6.4 ϫ 10 Ϫ10 mg dry wt. cell Ϫ1 (Liu et al., 2002b) and surface area of 140 m 2 g Ϫ1 (Fein et al., 1997; Sokolov et al., 2001) for S. putrefaciens CN32. Hematite surface area was 9.04 m 2 g Ϫ1 measured by N 2 -BET (Jeon et al., 2001 ).
Data analysis
Inhibition was defined as the percent change in the 5-day extent of hematite bioreduction due to metal addition relative to its biotic no-metal control (Sani et al., 2001 ) and calculated as:
where the bioreduction extent was measured after 5 days for hematite reduction. It is important to note that for each series of experiments (with or without amendment), inhibition was calculated relative to its corresponding biotic no-metal control. The inhibitory concentration of metal required for 50% reduction in microbial metal reduction (IC 50 ) was calculated according to the following equation:
where ␤ 0 was the y-axis intercept of the metal vs. percent inhibition regression line and ␤ 1 was the slope of the metal vs. percent inhibition regression line. 
RESULTS AND DISCUSSION
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Ȩ tion. The biotic no-amendment control series (o symbols) is included for comparative purposes, and was prepared independently from the amendment experiments. Data points on the y-axis of Fig. 1A represent biotic no-zinc controls for each series. These values were used in Equation (1) (fraction denominator) to determine inhibition at each zinc concentration, and the corresponding inhibition values were used in Equation (2) to calculate the IC 50 values for each experimental condition (Fig. 2) . The two amendment concentrations (1.46 mM ferrozine and 50 M AQDS) were selected because they enhanced hematite bioreduction (in the absence of zinc) (Royer et al., 2002b) . In the absence of zinc, both amendments stimulated hematite bioreduction (by 59 and 116% for ferrozine and AQDS, respectively) compared to the noamendment control. Low concentrations of zinc (Յ0.05 mM) stimulated Fe(II) production for both ferrozine and the no-amendment controls (Fig. 1A) . For the no-amendment controls, Fe(II) production increased by 22% with 0.05 mM total zinc compared to the no-amendment no-zinc control. Ferrozine addition increased Fe(II) production by 42% with 0.05 mM total zinc compared to the ferrozine no-zinc control. Fe(II) production for ferrozine and the no-862 STONE ET AL. 
F2
Ȥ amendment controls conformed to a Type II dose-response curve (stimulation followed by inhibition) as defined by Welp and Brummer (1997) , where maximum Fe(II) production occurred at low zinc concentrations while higher zinc concentrations resulted in decreased Fe(II) production. In the presence of AQDS, Fe(II) production decreased by 23% with 0.05 mM total zinc compared to the AQDS no-zinc control. Zinc addition at concentrations greater than 0.05 mM inhibited hematite bioreduction in the absence and presence of both amendments. Increasing zinc concentrations resulted in decreased freely dispersed cell viability (Fig. 1B) . In no-amendment controls without zinc, 82% of the cells were viable after 5 days (o data point on the y-axis), whereas no freely dispersed viable cells remained in the presence of 0.23 mM total zinc. Similar results were observed for the ferrozinecontaining control cultures; however less total zinc (0.13 mM) was required to achieve nearly no freely dispersed viable cells after 5 days. It is unknown why ferrozine increased zinc toxicity. Cell viability counts were not performed for the AQDS containing cultures due to interferences between the Baclight stain and AQDS.
The inhibition of hematite bioreduction vs. total zinc for each experimental series is presented in Fig. 2 . The regression lines were calculated only for total zinc concentrations that resulted in increased inhibition (Ն0.05 mM total zinc) compared to the corresponding no-zinc control. The IC 50 value for the no-amendment controls was 0.20 mM total zinc. Amendment addition lowered the IC 50 (i.e., zinc became more toxic) to 0.10 and 0.081 mM total zinc for ferrozine and AQDS, respectively. IC 50 values were also calculated based on dissolved zinc concentrations (results not shown). However, IC 50 values could not be calculated based on free Zn 2ϩ concentrations because zinc complexation reactions and constants with ferrozine and AQDS are presently unknown. A summary of the IC 50 values and the corresponding regression equations are presented in Table 1 .
Fe(II) and Zn(II) partitioning
The distribution of the divalent metals Fe(II), Zn(II), and Mn(II) between the solid (hematite and cell surfaces) and solution phases is important for interpretative reasons. Me(II) inhibition of hematite reduction could be caused by either Me(II) toxicity leading to cell death or Me(II) sorption leading to hematite surface blockage, or a combination of both. Sorbed Me(II) concentrations were calculated as the difference between the 0.5 N HCl extractable and dissolved Me(II) concentrations and are reported as mmol of Me(II) per m 2 total sorbent surface area (hematite and cells). A "baseline" Fe(II) sorption isotherm (solid line in Fig. 3A ) was developed from a series of hematite bioreduction experiments performed in the absence of any amendment (i.e., ferrozine, AQDS) or All experiments were performed with 2.0 g L Ϫ1 hematite and 10 8 cells mL Ϫ1 in 10 mM PIPES (pH 6.8) at 20°C; a defined as inhibitory concentration of zinc where a 50% reduction of 5-day extent of Fe(II) production occurred relative to a corresponding no-zinc control; b IC 50 values were calculated from the least-squares lines obtained from the data presented in Fig. 2 . metal (i.e., zinc, manganese). These experiments were performed with variable hematite concentrations (0.25-2.0 g L Ϫ1 ) and a constant initial cell concentration of 10 8 cells mL Ϫ1 . All data presented in Fig. 3A were determined from 1-to 5-day incubations. A Freundlich sorption isotherm (R 2 ϭ 0.891) was selected over a Langmuir isotherm (not shown; R 2 ϭ 0.735) due to a higher correlation coefficient. For consistency, Freundlich isotherms were used to describe metal partitioning for all results presented in this study ( Table 2 ). The sorption isotherm for Fe(II) was similar to abiotic results reported by Jeon et al. (2003) .
The effect of zinc on the partitioning of Fe(II) onto hematite and cells during hematite bioreduction is presented in Fig. 3B . The solid line represents the "baseline" no-zinc sorption isotherm (i.e., regression line from Fig.  3A ), while the dashed lines represent the 95% confidence intervals associated with the isotherm equation. Dissolved Fe(II) measurements were taken daily for up to 5 days. The highest dissolved Fe(II) concentration for each zinc concentration corresponded to the 5-day incubation. The majority of data points fell below the Fe(II) baseline isotherm (p Ͻ 0.05) suggesting that zinc decreased the partitioning of Fe(II) onto hematite and cells. The higher total zinc concentrations (0.10, 0.13, and 0.23 mM) produced the greatest decrease in Fe(II) partitioning, especially for the 5-day results, which had the highest dissolved Fe(II) concentrations.
Impact of amendments on Fe(II) and Zn(II) partitioning
The effects of 1.46 mM ferrozine or 50 M AQDS on Fe(II) partitioning are presented in Fig. 4A . The solid line represents the "baseline" Fe(II) sorption isotherm in the absence of amendments (from Fig. 3A) with the corresponding 95% confidence intervals. These data show that ferrozine significantly reduced (p Ͻ 0.05) Fe(II) partitioning to hematite and cells for all measured dissolved Fe(II) concentrations. Ferrozine has a reported maximum Fe(II) complexation capacity of 0.33 mol Fe(II) mol Ϫ1 ferrozine (Stookey, 1970) which, for the experimental conditions, was 0.48 mM Fe(II). This complexation capacity exceeded the total biogenic Fe(II) concentration produced in all but one condition (0.55 mM Fe(II) with 0.05 mM zinc; Fig. 1A) . AQDS also decreased (p Ͻ 0.05) Fe(II) partitioning for two of the three conditions presented in Fig. 4A .
The effect of the amendments on zinc partitioning to hematite and cells are presented in Fig. 4B . The "baseline" no-amendment with-biogenic-Fe(II) zinc sorption isotherm was derived from results presented in Fig. 3B while dashed lines represent 95% confidence intervals. These data show that, with one exception, zinc sorption was not significantly affected by ferrozine or AQDS. The one exception was the lowest zinc concentration when Fe(II) production was highest. For both amendments, zinc sorption did not increase compared to the no-amendment controls; therefore, sorbed zinc blocking hematite surface sites was not likely an important mechanism of inhibition of bioreduction.
Impact of manganese
Fe(II) production was consistent for manganese concentrations up 1.82 mM, where 0.5 N HCl extractable Fe(II) decreased from an average of 0.17 Ϯ 0.014 mM (n ϭ 7) to 0.10 mM (Fig. 5A) . Fe(II) production in the biotic no-manganese control was 0.17 Ϯ 0.017 mM (n ϭ 3) 0.5 N HCl extractable Fe(II Hematite ϩ LOG q ϭ 0.486*LOG C Ϫ 3.71 0.884 S. putrefaciens c,e a Values derived using Freundlich isotherm equation: LOG q ϭ log K f ϩ 1/n LOG C, where K f ϭ Freundlich adsorption capacity factor, and 1/n ϭ Freundlich adsorption intensity factor; b Results from no-amendment no-zinc hematite bioreduction experiments (Stone et al., 2006) ; c Cells estimated from 10 8 cells mL Ϫ1 concentration of cells with 6.4 ϫ 10 Ϫ10 mg cell Ϫ1 (Liu et al., 2002b) . Cell surface area estimated as 140 m 2 g Ϫ1 (Fein et al., 1997; Sokolov et al., 2001) ; 2.0 g L Ϫ1 hematite with estimated surface area of 9.04 m 2 g Ϫ1 (Jeon et al., 2001) 
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Ȩ dicated that manganese addition was not particularly lethal to cells (Ͼ80% viable) up to 0.91 mM manganese, beyond which viability decreased to 31% for 1.82 mM manganese.
The effect of manganese on the partitioning of Fe(II) onto hematite cells is presented in Fig. 5B . The solid line represents the "baseline" Fe(II) sorption isotherm (from Fig. 3A ) in the absence of manganese and the dashed lines represent 95% confidence intervals. Total manganese concentrations for these Fe(II) partitioning data ranged from 0.02 to 1.82 mM, while Fe(II) ranged from 0.10-0.20 mM 0.5 N HCl extractable Fe(II). The results show that manganese had no systematic effect on Fe(II) partitioning, in contrast to the decrease in Fe(II) partitioning observed in the presence of zinc (Fig.  3B ).
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STONE ET AL. Compared to zinc, manganese was far less lethal to S. putrefaciens CN32. At the highest manganese concentration tested (1.82 mM) 31% of cells were viable after a 5-day incubation period, while 0.23 mM zinc left 0% of the cells viable. Compared to zinc, manganese sorbed far less to hematite and cells (Fig. 6) . At identical total Me(II) concentrations of 0.23 mM, zinc decreased the 5-day extent of hematite bioreduction by 63.8%, while manganese increased hematite bioreduction by 17.0% (Fig. 7) 
SUMMARY
The relationships between sorbed and "free" Me(II) were assessed to predict Me(II) inhibition during the bioreduction of solid-phase iron(III) oxide. Previous studies suggest that "shielding" of zinc by solid-phase electron acceptors (i.e., hematite) may be responsible for the decreased sensitivity of free Zn 2ϩ compared to aqueous electron acceptors. However, results from this study indicate increased surface sorbed Me(II) may not be responsible for the inhibition effects observed during hematite bioreduction. The addition of AQDS and ferrozine amendments did not increase Me(II) sorption, thus suggesting sorbed Me(II) likely was not responsible for the increased inhibition effects observed. Dissimilarities between zinc and manganese inhibition effects for both Me(II) addition and surface partitioning behavior further show Me(II) toxicity appears more important than Me(II) sorption for inhibiting hematite bioreduction. These results further advance the understanding of Me(II) inhibition mechanisms that occur during biological remediation efforts. Recognizing the interactions between Me(II) and bioreduction enhancement amendments is critical for the determination of effective bioremediation strategies
